Skip to content

effect of meloxib & physiotherapy in TMD

Comparison of the effect of Meloxib with physical therapy (TENS & infrared) on improvement of TMD symptoms in the referrals to Qom medical clinics in 2018-2019

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20181113041642N1
Enrollment
46
Registered
2020-03-28
Start date
2018-12-21
Completion date
Unknown
Last updated
2020-04-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

temporomandibulr disorder.

Interventions

Intervention 1: Intervention group1: tab meloxibe 7.5 mg , for 30 days, once a day. Intervention 2: Intervention group 2: physiotherapy (tens & infrared), 10 session, 3 times in week for 4 week, 20

Sponsors

Ghoum University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
15 Years to 60 Years

Inclusion criteria

Inclusion criteria: Patients with a history of myofacial pain of TMD Both sexes Aged 15-60 years

Exclusion criteria

Exclusion criteria: Arthritis and other systemic joint diseases Articular dislocation

Design outcomes

Primary

MeasureTime frame
Masticatory muscles tenderness. Timepoint: First and last day (30) of study. Method of measurement: questionnaire and examination.;Joint sounds. Timepoint: first and last day of study. Method of measurement: questionnaire and examination.;Mouth opening limitation. Timepoint: first and last day of study. Method of measurement: questionnaire and examination.;Subluxation. Timepoint: first and last day of study. Method of measurement: questionnaire and examination.;Deviation. Timepoint: first and last day of study. Method of measurement: questionnaire and examination.;Limitation on lateral movement. Timepoint: first and last day of study. Method of measurement: questionnaire and examination.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohammad Mehdizadh

Ghoum University of Medical Sciences

Mehdizadehmo19@gmail.com+98 25 3770 0094

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026